Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Corrigendum to “Histone-lysine...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Corrigendum to “Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients” [EBioMedicine 37 (2018) 134–143]

Corrigendum to “Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients” [EBioMedicine 37 (2018) 134–143]

Bibliographic Details
Main Authors: Baojun Duan, Jun Bai, Jian Qiu, Jianhua Wang, Cong Tong, Xiaofei Wang, Jiyu Miao, Zongfang Li, Wensheng Li, Juan Yang, Chen Huang
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396423001457
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2352396423001457

Similar Items

  • Lysine methyltransferase SETD6 modifies histones on a glycine-lysine motif
    by: Olivier Binda
    Published: (2020-02-01)
  • Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton
    by: Christina Michail, et al.
    Published: (2025-01-01)
  • EBioMedicine: Bridging Two Cultures to Improve Health
    Published: (2014-11-01)
  • Histone Lysine Methyltransferase SETD2 Regulates Coronary Vascular Development in Embryonic Mouse Hearts
    by: Fengling Chen, et al.
    Published: (2021-04-01)
  • Retraction notice to “Corrigendum to ‘MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway’ [EBioMedicine 46 (2019) 66–78]” [EBioMedicine 55 (2020) 102772]
    by: Wei-Wei Wang, et al.
    Published: (2024-05-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs